97504 ⎘
Preparation of polysaccharides not provided for in groups - ; Derivatives thereof; Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof; Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan; Heparin; Heparan sulfate; Derivatives thereof, e.g. heparosan; Purification or extraction methods thereof Degradation products
SYNTHETIC HEXASACCHARIDES MIMICS OF HEPARIN SHOWING HEPARANASE INHIBITION ACTIVITY
#2DERIVATIVES OF N-DESULFATED GLYCOSAMINOGLYCANS AND USE AS DRUGS
#3Process for the preparation of low molecular weight heparin
#4Derivatives of N-desulfated glycosaminoglycans and use as drugs
#5Process for the preparation of Dalteparin sodium
#6Derivatives of N-desulfated glycosaminoglycans and use as drugs
#7Carboxylated derivatives of glycosaminoglycans and use as drugs
#8Carboxylated derivatives of glycosaminoglycans and use as drugs
#9SULFATED HEPARIN OLIGOSACCHARIDE AND PREPARATION METHOD AND APPLICATION THEREOF
#10PDGF-B /PDGF-BB binding variants of heparan sulfates
#11Carboxylated Derivatives of Glucosaminoglycans and Use as Drugs
#12Modulation of the physical interaction between platelets and the cell surface effecting cell proliferation
#13Carboxylated derivatives of glycosaminoglycans and use as drugs
#14Derivatives of N-desulfated glycosaminoglycans and use as drugs
#15Heparan sulphates
#16POLYSACCHARIDE COMPOSITIONS AND METHODS OF USE FOR THE TREATMENT AND PREVENTION OF DISORDERS ASSOCIATED WITH PROGENITOR CELL MOBILIZATION
#17Glycosaminoglycans
#18MULTIVALENT ANTIVIRAL COMPOSITIONS, METHODS OF MAKING, AND USES THEREOF
#19High purity heparin and production method therefor
#20Low anticoagulant heparins
#21Use of chemically modified heparin derivates in sickle cell disease
#22Process for the preparation of highly O-sulfated, epimerized derivatives of K5 polysacchride and intermediates therein
#23Oligosaccharide compounds
#24Polysaccharide compositions and methods of use for the treatment and prevention of disorders associated with progenitor cell mobilization
#25Polysaccharide compositions and methods of use for the treatment and prevention of disorders associated with progenitor cell mobilization
#26Capillary electrophoresis method for fine structural analysis of enoxaparin sodium
#27High purity heparin and production method therefor
#28Methods and compositions for promoting hair growth
#29Glycosaminoglycans
#30PROCESS FOR THE PREPARATION OF HIGHLY O-SULFATED EPIMERIZED DERIVATIVES OF K5 POLYSACCHARIDE AND INTERMEDIATES THEREIN
#31Methods of making and using surfactant polymers
#32USE OF AN ACYLATED OCTASACCHARIDE AS AN ANTITHROMBOTIC AGENT
#33Acylated decasaccharides and their use as antithrombotic agents
#34Sulfated heptasaccharide and its use as an antithrombotic agent
#35SULFATED OCTASACCHARIDE AND ITS USE AS ANTITHROMBOTIC AGENT
#36Acylated 1,6-anhydro decasaccharide and its use as an antithrombotic agent
#37MIXTURES OF POLYSACCHARIDES DERIVED FROM HEPARIN, THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
#38Evaluating heparin preparations
#39Mixtures of polysaccharides derived from heparin, their preparation and pharmaceutical compositions containing them
#40Oxidized heparin fractions and their use in inhibiting angiogenesis
#41OLIGOSACCHARIDE MIXTURES DERIVED FROM HEPARIN, PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
#42COMPOSITIONS OF POLYSACCHARIDES DERIVED FROM HEPARIN, THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
#43Heparan sulfate glycosaminoglycan lyase and uses thereof
#44Epimerized derivatives of K5 polysaccharide with a very high degree of sulfation
#45Polysaccharide compositions and methods of use for the treatment and prevention of disorders associated with progenitor cell mobilization
#46Polysaccharide compositions and methods of use for the treatment and prevention of disorders associated with progenitor cell mobilization
#47LOW MOLECULAR WEIGHT HEPARIN COMPOSITION AND USES THEREOF
#48Non-anticoagulant polysaccharide compositions
#49OLIGOSACCHARIDES, PREPARATION METHOD AND USE THEREOF, AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME
#50Heparan sulfate glycosaminoglycan lyase and uses thereof
#51USE FOR A VERY LOW MOLECULAR WEIGHT HEPARINS
#52PROCESS FOR THE PRODUCTION OF A LOW MOLECULAR WEIGHT HEPARIN
#53Method for determining specific groups constituting heparins or low molecular weight heparins
#54Process for the preparation of N-acyl-(epi)K5-amine-O-sulfate-derivatives and products thus obtained
#55Process for oxidizing unfractionated heparins and detecting presence or absence of glycoserine in heparin and heparin products
#56Composition forstimulating bone growth and differentiation and method for isolating same
#57Methods of making and using surfactant polymers
#58Mixtures of sulfated oligosaccharides
#59Orthogonally protected disaccharide building blocks for synthesis of heparin
#60Heparan Sulfate Glycosaminoglycan Lyase and Uses Thereof
#61Glycosaminoglycan lyase IV and uses thereof
#62Heparin compositions that inhibit clot associated coagulation factors
#63Low molecular weight heparin composition and uses thereof
#64Rationally designed heparinases derived from heparinase II
#65Oligosaccharides, preparation method and use thereof, and pharmaceutical compositions containing same
#66Heparan sulfate glycosaminoglycan lyase and uses thereof
#67Heparan sulfate glycosaminoglycan lyase and uses thereof
#68Multistep process for the physical depolymerization of heparin and products obtained therefrom
#69Hgf production accelerator containing heparin-like oligosaccharide
#70Process for the physical depolymerization of glycosaminoglycanes and products obtained therefrom
#71Rationally designed heparinases derived from heparinase I and II and methods of sequencing therewith
#72Orthogonally protected disaccharide building blocks for synthesis of heparin oligosaccharides
#73Epimerized derivatives of K5 polysaccharide with a very high degree of sulfation
#74Composition for stimulating bone growth and differentiation and method for isolating same
#75Process for the manufacture of n-acyl-(epi)k5-amine-o-sulfate-derivatives and products thus obtained
#76Low molecular weight oversulfated polysaccharide
#77Process for the physical depolymerization of glycosaminogylcanes and products obtained thereform
#78Low molecular weight heparin salt with triethanolamine useful as therapeutic-antitrombotic agent of local delivery, procedures for preparing them, process for elimination of hygroscopicity of heparin salt, pharmaceutical compositions for local use in antithrombotic therapy and uses therein
#79Process for oxidizing unfractionated heparins and detecting presence or absence of glycoserine in heparin and heparin products
#80Method for determining specific groups constituting heparins or low molecular weight heparins
#81Compositions of polysaccharides derived from heparin, their preparation and pharmaceutical compositions containing them
#82Process for producing sugar in which molecular weight is lowered
#83Derivatives of partially desulphated glycosaminoglycans as heparanase inhibitors, endowed with antiangiogenic activity and devoid of anticoagulating effect
#84Saccharide sulfation methods
#85Oligosaccharide mixtures derived from heparin, preparation thereof and pharmaceutical compositions containing them
#86Process for preparing high purity low molecular weight heparins
#87Modified low molecular weight heparin that inhibits clot associated coagulation factors